Masiero M et al 10 reported that ELTD1-silenced CRC cells grew slowly in xenograft tumors, while CRC patients with higher ELTD1 expression in tumor-associated endothelial cells had better prognosis. This evidence concerns the gene ADGRL4 and colorectal carcinoma.